Your browser doesn't support javascript.
loading
Guidelines for quality control of PET/CT scans in a multicenter clinical study.
Hristova, Ivalina; Boellaard, Ronald; Galette, Paul; Shankar, Lalitha K; Liu, Yan; Stroobants, Sigrid; Hoekstra, Otto S; Oyen, Wim J G.
Afiliação
  • Hristova I; Department of Nuclear Medicine, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands. ivalinahr@gmail.com.
  • Boellaard R; European Organization for Research and Treatment of Cancer, Imaging Group, Brussels, Belgium. ivalinahr@gmail.com.
  • Galette P; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Shankar LK; European Organization for Research and Treatment of Cancer, Imaging Group, Brussels, Belgium.
  • Liu Y; GSK, Experimental Medicine Imaging, Upper Providence, PA, USA.
  • Stroobants S; Division of Cancer Treatment and Diagnosis National Cancer Institute, Bethesda, MD, USA.
  • Hoekstra OS; European Organization for Research and Treatment of Cancer, Imaging Group, Brussels, Belgium.
  • Oyen WJG; European Organization for Research and Treatment of Cancer, Headquarters, Brussels, Belgium.
EJNMMI Phys ; 4(1): 23, 2017 Sep 18.
Article em En | MEDLINE | ID: mdl-28924696
ABSTRACT
To date, there is no published detailed checklist with parameters referencing the DICOM tag information with respect to the quality control (QC) of PET/CT scans. The aims of these guidelines are to provide the know-how for effectively controlling the quality of PET/CT scans in multicenter studies, to standardize the QC, to give sponsors and regulatory agencies a basis for justification of the data quality when using standardized uptake values as an imaging biomarker, to document the compliance with the imaging guidelines, to verify the per protocol population versus intent to treat population, and to safeguard the validity of multicenter study conclusions employing standardized uptake value (SUV) as an imaging biomarker which is paramount to the scientific community. Following the proposed guidelines will ensure standardized prospective imaging QC of scans applicable to most studies where SUVs are used as an imaging biomarker. The multitude of factors affecting SUV measurements when not controlled inflicts noise on the data. Decisions on patient management with substantial noise would be devastating to patients, ultimately undermine treatment outcome, and invalidate the utility of SUV as an imaging biomarker usefulness. Strict control of the data quality used for the validation of SUV as an imaging biomarker would ensure trust and reliability of the data.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article